Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain-Mediated Metabolite Formation

0Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Invited for the cover of this issue is the group of Hans-Georg Lerchen and colleagues from Bayer AG R&D Pharmaceuticals. The image, provided by J. Franz and graphic designers from The New Atlantic (Cologne), depicts a cartoon representation of the legumain-mediated cleavage of the peptide cap within the lysosome. Read the full text of the article at 10.1002/chem.201900441.

Cite

CITATION STYLE

APA

Lerchen, H. G., Stelte-Ludwig, B., Berndt, S., Sommer, A., Dietz, L., Rebstock, A. S., … Greven, S. (2019, June 21). Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain-Mediated Metabolite Formation. Chemistry - A European Journal. Wiley-VCH Verlag. https://doi.org/10.1002/chem.201901770

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free